Van Roosmalen et al. reported that reduced SRPK1 expression suppressed the migration of BLBC cells in vitro and breast cancer metastasis to the lungs in vivo through interacting with the NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) pathway [33]. The gene discussed is SRPK1; the disease is breast cancer.